These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2572374)

  • 21. Efficacy and safety of nicardipine in 29,104 patients with hypertension.
    Dubois C; Blanchard D
    Clin Ther; 1989; 11(4):452-60. PubMed ID: 2673515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal protective effect of strict blood pressure control with enalapril therapy.
    Bauer JH; Reams GP; Lal SM
    Arch Intern Med; 1987 Aug; 147(8):1397-400. PubMed ID: 2820330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C; Del Vecchio L; Locatelli F
    G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
    Velasco M; Morillo J; Urbina A; Kögler P; Leishman B; Pasquier M; Hernändez-Pieretti O
    Int J Clin Pharmacol Res; 1987; 7(6):443-54. PubMed ID: 3440635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antihypertensive effects of intravenous nicardipine in arterial hypertension in the elderly].
    Escande M; David D; Diadema B
    Therapie; 1989; 44(3):161-5. PubMed ID: 2675376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
    Clin Ther; 1993; 15(2):364-73. PubMed ID: 8519044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease.
    Omata K; Kanazawa M; Sato T; Abe F; Saito T; Abe K
    Kidney Int Suppl; 1996 Jun; 55():S57-62. PubMed ID: 8743512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicardipine versus nifedipine: multicentre controlled trial in essential hypertension.
    Rumboldt Z; Stojanova D; Drinovec J; Marinković M; Nesović M; Srbinovski M; Bagatin J; Nikodijević B; Stalc A
    Int J Clin Pharmacol Res; 1988; 8(6):393-400. PubMed ID: 3075601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of i.v. nicardipine in the treatment of hypertensive crisis].
    Bolognesi R; Tsialtas D; Straneo U; Conti M; Manca C
    Minerva Cardioangiol; 1990 Jun; 38(6):299-303. PubMed ID: 2250772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antihypertensive effect and tolerability of slow-release nicardipine].
    Fogari R; Poletti L; Tettamanti F; Malamani G; Borgnino C
    Cardiologia; 1989 Feb; 34(2):161-5. PubMed ID: 2660993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twice-daily nicardipine in the treatment of essential hypertension.
    Charlap S; Kimmel B; Laifer L; Weinberg P; Singer M; Lazar E; Saltzberg S; Dorsa F; Kafka K; Strom J
    J Clin Hypertens; 1986 Sep; 2(3):271-7. PubMed ID: 3537214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of the reno-protective effect of short- and long-acting antihypertensive agents in IgA nephropathy].
    Vas T; Kovács T; Szelestei T; Csiky B; Nagy J
    Orv Hetil; 1999 Sep; 140(36):1991-5. PubMed ID: 10506823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of a combination of enalapril and hydrochlorothiazide in the treatment of hypertension measured manually and with an ambulatory blood pressure monitor.
    Weir MR; Lavin PT; Byrnes CA
    Clin Ther; 1993; 15(3):527-38. PubMed ID: 8364944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of the antihypertensive effect of enalapril by randomized addition of different doses of hydrochlorothiazide.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
    J Hypertens Suppl; 1985 Dec; 3(3):S483-6. PubMed ID: 2856773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
    Applegate W; Cohen JD; Wolfson P; Davis A; Green S
    Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of enalapril monotherapy and enalapril/hydrochlorothiazide combination therapy on blood pressure, renal function, and body fluid composition.
    Reams GP; Bauer JH
    J Clin Hypertens; 1986 Mar; 2(1):55-63. PubMed ID: 3014081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term haemodynamic effects of enalapril (alone and in combination with hydrochlorothiazide) at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    J Hypertens Suppl; 1984 Dec; 2(2):S49-56. PubMed ID: 6100877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of the pharmacodynamics and pharmacokinetics of nicardipine combined with enalapril in essential hypertension.
    Donnelly R; Elliott HL; Meredith PA; Reid JL
    J Cardiovasc Pharmacol; 1987 Dec; 10(6):723-7. PubMed ID: 2450244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.